Amolyt Pharma is a series c plus startup based in France. 2 investors tracked on Brouky Intelligence. Status: acquired. Data sourced from Brouky Intelligence.
About
Amolyt Pharma is a clinical-stage biotechnology company specializing in the development of therapeutic peptides for rare endocrine and related diseases.
Stage
series-c-plus
Investors
2
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky